Suppr超能文献

呼吸困难与 COPD 发生率、心脏事件和全因死亡率:从中年到整个生命的 44 年随访。

Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.

机构信息

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund, Sweden.

Dept of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

出版信息

PLoS One. 2019 Mar 18;14(3):e0214083. doi: 10.1371/journal.pone.0214083. eCollection 2019.

Abstract

BACKGROUND

Breathlessness is prevalent in the general population and may be associated with adverse health outcomes. This study aimed to evaluate the association of breathlessness with Chronic Obstructive Pulmonary Disease (COPD) events, cardiac events and all-cause mortality from middle-age throughout life.

METHODS

Breathlessness was measured in 699, 55-year old men residing in Malmö, Sweden using modified Medical Research Council (mMRC). COPD events (hospitalisation, death or diagnosis) cardiac events and all-cause mortality was assessed using The Swedish Causes of Death Register and Hospital Discharge Register. Data was analyzed using Cox- and competing risks (Fine-Gray) regression analysis.

RESULTS

695 (99%) of 699 participants died and four emigrated during follow up. Eighty-seven (12%) had mMRC = 1 and 19 (3%) had mMRC≥2. Breathlessness was associated with COPD events; adjusted Sub-Hazard Ratio 2.1 (95% CI, 1.2-3.6) for mMRC = 1 and 7.5 (2.6-21.7) for mMRC ≥ 2 but not associated with cardiac events when adjusting for competing events and confounding. Breathlessness was associated increased all- cause mortality (Hazard Ratios of 1.4 (1.1-1.7) (mMRC = 1) and 3.4 (2.1-5.6) (mMRC ≥ 2)).

CONCLUSION

Breathlessness is associated with increased risk of COPD events and increase in all-cause mortality from age 55 until death.

摘要

背景

呼吸困难在普通人群中很常见,可能与不良健康结果有关。本研究旨在评估呼吸困难与慢性阻塞性肺疾病(COPD)事件、心脏事件以及从中年到生命结束的全因死亡率之间的关系。

方法

在瑞典马尔默,使用改良版医学研究委员会(mMRC)量表对 699 名 55 岁男性进行呼吸困难测量。使用瑞典死因登记处和住院记录登记处评估 COPD 事件(住院、死亡或诊断)、心脏事件和全因死亡率。使用 Cox 和竞争风险(Fine-Gray)回归分析进行数据分析。

结果

699 名参与者中,有 695 人(99%)在随访期间死亡,4 人移民。87 人(12%)的 mMRC=1,19 人(3%)的 mMRC≥2。呼吸困难与 COPD 事件相关;调整竞争事件和混杂因素后,mMRC=1 的调整后的亚危险比为 2.1(95%CI,1.2-3.6),mMRC≥2 的为 7.5(2.6-21.7)。但与心脏事件无关。呼吸困难与全因死亡率增加相关(mMRC=1 的危险比为 1.4(1.1-1.7),mMRC≥2 的为 3.4(2.1-5.6))。

结论

呼吸困难与 COPD 事件风险增加以及 55 岁至死亡期间全因死亡率增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c010/6422305/ed080d2dd84b/pone.0214083.g001.jpg

相似文献

1
Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.
PLoS One. 2019 Mar 18;14(3):e0214083. doi: 10.1371/journal.pone.0214083. eCollection 2019.
2
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2016 Nov 9;11:2805-2812. doi: 10.2147/COPD.S119992. eCollection 2016.
4
Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.
Int J Chron Obstruct Pulmon Dis. 2018 Nov 28;13:3857-3865. doi: 10.2147/COPD.S175641. eCollection 2018.
5
Differences in physical activity according to mMRC grade in patients with COPD.
Int J Chron Obstruct Pulmon Dis. 2016 Sep 13;11:2203-2208. doi: 10.2147/COPD.S109694. eCollection 2016.
6
Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.
J Pain Symptom Manage. 2018 Sep;56(3):430-435.e2. doi: 10.1016/j.jpainsymman.2018.05.002. Epub 2018 May 10.
8
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.
9
The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness.
Clin Res Cardiol. 2019 Feb;108(2):185-193. doi: 10.1007/s00392-018-1342-z. Epub 2018 Aug 8.

引用本文的文献

1
Risk factors for mortality in Finnish bronchiectasis patients: A four-year study.
Chron Respir Dis. 2025 Jan-Dec;22:14799731251358596. doi: 10.1177/14799731251358596. Epub 2025 Aug 17.
2
Abnormally high exertional breathlessness predicts mortality in people referred for incremental cycle exercise testing.
PLoS One. 2024 Dec 18;19(12):e0302111. doi: 10.1371/journal.pone.0302111. eCollection 2024.
4
Associations in Perceived Health and Persistent Breathlessness: A Cross-Sectional Study.
Palliat Med Rep. 2023 Apr 20;4(1):120-126. doi: 10.1089/pmr.2022.0071. eCollection 2023.
5
Respiratory symptoms and cardiovascular causes of deaths: A population-based study with 45 years of follow-up.
PLoS One. 2022 Oct 20;17(10):e0276560. doi: 10.1371/journal.pone.0276560. eCollection 2022.
6
Prognostic value of lymphocyte count for in-hospital mortality in patients with severe AECOPD.
BMC Pulm Med. 2022 Oct 5;22(1):376. doi: 10.1186/s12890-022-02137-1.
7
Risk Factors for Postoperative Pneumonia: A Case-Control Study.
Front Public Health. 2022 Jul 8;10:913897. doi: 10.3389/fpubh.2022.913897. eCollection 2022.
9
Prevalence and severity of differing dimensions of breathlessness among elderly males in the population.
ERJ Open Res. 2021 Feb 7;8(1). doi: 10.1183/23120541.00553-2021. eCollection 2022 Jan.

本文引用的文献

1
The 2017 Global Initiative for Chronic Obstructive Lung Disease Report and Practice Implications for the Respiratory Therapist.
Respir Care. 2017 Nov;62(11):1492-1500. doi: 10.4187/respcare.05402. Epub 2017 Sep 5.
3
Dyspnea as an independent predictor of mortality.
Clin Respir J. 2016 Mar;10(2):142-52. doi: 10.1111/crj.12191. Epub 2014 Aug 20.
4
Predictors of dyspnoea prevalence: results from the BOLD study.
Eur Respir J. 2014 Jun;43(6):1610-20. doi: 10.1183/09031936.00036813. Epub 2013 Oct 31.
5
Validation of a COPD diagnosis from the Swedish Inpatient Registry.
Scand J Public Health. 2012 Dec;40(8):773-6. doi: 10.1177/1403494812463172. Epub 2012 Oct 19.
6
Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.
Eur J Epidemiol. 2012 Nov;27(11):867-76. doi: 10.1007/s10654-012-9736-0. Epub 2012 Oct 7.
7
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST.
8
An algorithmic approach to chronic dyspnea.
Respir Med. 2011 Jul;105(7):1014-21. doi: 10.1016/j.rmed.2010.12.009. Epub 2011 Jan 7.
9
Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice.
Int J Clin Pract. 2007 Sep;61(9):1481-91. doi: 10.1111/j.1742-1241.2007.01428.x.
10
Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men.
J Intern Med. 2006 Oct;260(4):332-42. doi: 10.1111/j.1365-2796.2006.01693.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验